Saturday | 30 August, 2008
Stories about: Axon
- +
Slimeballs and eyeballs: hagfish and the evolution of the eye 11/04/2008 13:28:33
Hagfish may be ferociously ugly little creatures, but they can teach us much about the evolution of the vertebrate eye. - +
More than just auditory cheesecake 29/01/2008 12:34:43
Alan Harvey will discuss neurotrauma research, Cliff Richard and the role of music in the evolution of the modern mind at the ANS meeting this week. - +
In brief: Benitec, Biota, Eqitx 09/02/2006 14:55:12
Benitec (ASX:BLT) has appointed former Axon Instruments VP Michael Catelani as executive director and Boron Molecular founder Peter Francis as non-executive director. - +
In brief: C3, SSH, Axon 30/11/2005 14:26:07
Clinical Cell Culture's (ASX:CCE) co-founder Prof Fiona Wood will step down from the company's board on December 31. She will remain as a consultant, an R&D partner through her research vehicle the McComb Foundation, and a substantial shareholder. - +
Circadian clocks up $21.8m profit 03/08/2005 14:51:35
Veteran biotech investment group Circadian Technologies (ASX:CIR) has posted an AUD$21.77 million profit before tax for the 2004/05 financial year, up from $5.8 million for the previous corresponding year. - +
What Alan Finkel did next 23/05/2005 14:22:57
Ruth Beran discovers how one of Australia's great bioentrepreneurs has moved from inspiring shareholders to inspiring a nation. - +
How to build your own Axon Instruments 23/05/2005 14:20:59
Australian Biotechnology News journalist Ruth Beran asked Axon Instruments founder Alan Finkel if he had any advice for Australian companies with an eye on the world stage. Here is his reply. - +
Axon, C3 alumni among Clunies Ross winners 03/05/2005 14:45:34
Bioscience entrepreneurs, including Axon Instruments founder Alan Finkel and Fiona Wood and Marie Stoner of Clinical Cell Culture, have dominated the winners' circle at this year's ATSE Clunies Ross Awards. - +
Molecule may be key to spinal cord regeneration 18/11/2004 13:55:19
Researchers at the Queensland Brain Institute and the University of Melbourne have identified a molecule which they believe may play a crucial role in preventing spinal cord regeneration. - +
Circadian returns capital to investors 25/08/2004 15:23:14
Long-time biotech investment group Circadian (ASX: CIR) is planning to return AUD$0.50 cents per share to investors after posting a $5.8 million profit for the 2003-2004 financial year with an even better profit forecast for next year. - +
Circadian returns capital to investors 25/08/2004 15:23:14
Long-time biotech investment group Circadian (ASX: CIR) is planning to return AUD$0.50 cents per share to investors after posting a $5.8 million profit for the 2003-2004 financial year with an even better profit forecast for next year.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Beyond The Hybrid TV Card Norm 2008-08-26 15:29:00+10
Go Green with Kingston - Save the PCB, Save the World 2008-08-25 16:10:00+10
VIA Pico-ITX at the Heart of Modern Robots 2008-08-25 13:50:00+10
Fujitsu unveils winning formula for success with Intel® Centrino® 2 processor technology. 2008-08-25 12:42:00+10
Multimedia Technology & Herma Technologies announce new audience feedback solution from REPLY Systems. 2008-08-19 11:05:00+10
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector. ALS is available free of charge to qualified persons working in the life sciences - register now for your free subscription.
